What is Fabry Disease: Symptoms, Causes & Treatment?

Name: Post Title
Creator: Liv Hospital
Published: 2026-01-01

Understand Fabry disease, a rare X-linked lysosomal storage disorder caused by alpha-galactosidase A deficiency. Discover its symptoms, causes, and treatment approaches.

Aslı Köse

Valdori Content Team

Summarize with

ChatGPT Perplexity Claude Grok Google

What is Fabry Disease: Symptoms, Causes & Treatment? 4

Fabry disease, also known as Anderson-Fabry disease, is a rare genetic disorder. It affects about 1 in 40,000 people. It happens because the body doesn’t have enough of the enzyme alpha-galactosidase A.

This leads to a buildup of a fatty substance called globotriaosylceramide in cells. This buildup causes many symptoms that can affect different parts of the body.

These symptoms can be serious, like kidney failure, heart failure, and stroke. Knowing about Fabry disease is key for early diagnosis and treatment.

At Liv Hospital, we focus on rare genetic disorders like Fabry disease. We aim to give top-notch care and support to patients from around the world.

Key Takeaways

Fabry disease is a rare genetic disorder caused by alpha-galactosidase A enzyme deficiency.
The condition leads to the accumulation of globotriaosylceramide in cells, causing various symptoms.
Potential complications include kidney failure, heart failure, and stroke.
Timely diagnosis and effective management are key for better outcomes.
Liv Hospital offers specialized care for international patients with Fabry disease.

Understanding Fabry Disease and Alpha Galactosidase Deficiency

Fabry disease comes from a genetic mutation. It affects the body because of a lack of alpha-galactosidase A. This enzyme is key for breaking down certain fats in our cells.

What is Fabry Disease?

Fabry disease happens when the body can’t break down certain fats. This leads to a buildup of harmful substances in cells. These substances damage organs like the skin, kidneys, heart, and brain.

Key aspects of Fabry disease include:

Genetic mutation in the GLA gene
Deficiency of alpha-galactosidase A enzyme
Accumulation of globotriaosylceramide
Multi-organ involvement

Prevalence and Demographics

Fabry disease is rare, affecting about 1 in 40,000 to 1 in 60,000 males. Females can also get it, but symptoms are usually milder.

The disease can start at any age. Early diagnosis is key to managing it and avoiding serious problems.

How Fabry Disease Affects the Body

Fabry disease harms many parts of the body. It causes problems like kidney failure, heart issues, and nerve damage. It also leads to skin problems like angiokeratomas.

Renal failure
Cardiac issues, such as hypertrophic cardiomyopathy
Neurological problems, including pain and neuropathy
Dermatological manifestations, such as angiokeratomas

Knowing about Fabry disease helps doctors give better care. They can target treatments to help patients live better lives.

Symptoms and Complications of Fabry Disease

It’s important to know the symptoms and complications of Fabry disease for early diagnosis and treatment. This genetic disorder, caused by alpha-galactosidase deficiency, affects many parts of the body.

Early Signs and Symptoms

Fabry disease often shows up in early childhood. Symptoms include acroparesthesia, angiokeratomas, corneal dystrophy, and hypohidrosis or anhidrosis. These signs suggest the disease and need further checks.

Other symptoms are abnormal sensations in hands and feet, cloudy or streaked corneas, dizziness, stomach issues, hearing loss, and trouble with heat or cold. An expert says,

Organ-Specific Complications

Untreated Fabry disease can cause serious problems in specific organs. These issues include cardiac hypertrophic cardiomyopathy, kidney failure, and brain problems.

The kidneys are hit hard, leading to chronic kidney disease or end-stage renal disease in many. Keeping an eye on kidney health is key for Fabry disease patients.

Early diagnosis and treatment can greatly improve life for those with Fabry disease. Knowing the symptoms and complications helps doctors provide better care.

Diagnosis and Treatment Options

Diagnosing Fabry disease requires enzyme assays and genetic testing. These tests check for a lack of alpha-galactosidase A. They are key to identifying the disease and finding the right treatment.

We have several treatments for Fabry disease. Enzyme replacement therapy adds the missing enzyme. Oral chaperone therapy fixes the faulty enzyme. These methods help manage symptoms and improve life quality.

Our institution is committed to top-notch healthcare for international patients. We aim to provide personalized care. This ensures patients get the best treatment and enjoy better health.

FAQ’s:

What is Fabry disease?

Fabry disease is a rare inherited lysosomal storage disorder caused by deficiency of the enzyme alpha-galactosidase A, leading to buildup of globotriaosylceramide (GL-3) in the body.

What are the symptoms of Fabry disease?

Symptoms include burning pain in hands and feet, angiokeratomas, reduced sweating, gastrointestinal issues, kidney damage, heart problems, and increased stroke risk.

How is Fabry disease diagnosed?

Fabry disease is diagnosed through enzyme activity testing, genetic testing of the GLA gene, and evaluation of kidney, heart, or neurological involvement.

What are the treatment options for Fabry disease?

Treatment options include enzyme replacement therapy, oral chaperone therapy, pain management, and supportive care for organ complications.

What is alpha-galactosidase A deficiency?

Alpha-galactosidase A deficiency is the underlying enzyme defect in Fabry disease that prevents proper breakdown of GL-3, causing its accumulation in cells.